| 12473360 |
Multi-specific antibody constructs |
Gerhard Frey, Hwai Wen Chang |
2025-11-18 |
|
| 12427347 |
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof |
Gerhard Frey, Hwai Wen Chang |
2025-09-30 |
|
| 12311032 |
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Hwai Wen Chang, Gerhard Frey |
2025-05-27 |
|
| 12187801 |
Chimeric antigen receptors against AXL or ROR2 and methods of use thereof |
Gregory I. Frost, James Onuffer, Gerhard Frey, Hwai Wen Chang |
2025-01-07 |
|
| 12110611 |
Conditionally active biological proteins |
Hwai Wen Chang, Gerhard Frey |
2024-10-08 |
$3,003,000 |
| 11976381 |
Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
— |
2024-05-07 |
$4,035,000 |
| 11897959 |
Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof |
Hwai Wen Chang, Gerhard Frey |
2024-02-13 |
$2,919,000 |
| 11879011 |
Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereof |
Hwai Wen Chang, Gerhard Frey |
2024-01-23 |
$2,203,000 |
| 11851499 |
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof |
Gerhard Frey, Hwai Wen Chang |
2023-12-26 |
$2,865,000 |
| 11834472 |
Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Gerhard Frey, Hwai Wen Chang, William J. Boyle |
2023-12-05 |
$1,582,000 |
| 11773509 |
Conditionally active polypeptides and methods of generating them |
Hwai Wen Chang, Gerhard Frey |
2023-10-03 |
$1,723,000 |
| 11718844 |
Mirac proteins |
Hwai Wen Chang, Gerhard Frey |
2023-08-08 |
$4,061,000 |
| 11639365 |
Methods of protein evolution |
— |
2023-05-02 |
$5,866,000 |
| 11584927 |
Conditionally active chimeric antigen receptors for modified T-cells |
— |
2023-02-21 |
$5,413,000 |
| 11542332 |
Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Gerhard Frey, Hwai Wen Chang |
2023-01-03 |
$12,176,000 |
| 11472876 |
Conditionally active polypeptides |
Hwai Wen Chang, Gerhard Frey |
2022-10-18 |
$7,747,000 |
| 11396717 |
Comprehensive monoclonal antibody generation |
— |
2022-07-26 |
$1,247,000 |
| 11396556 |
Express humanization of antibodies |
— |
2022-07-26 |
$1,247,000 |
| 11293929 |
Proteins targeting orthologs |
— |
2022-04-05 |
$2,821,000 |
| 11279924 |
Conditionally active polypeptides and methods of generating them |
Hwai Wen Chang, Gerhard Frey |
2022-03-22 |
$2,688,000 |
| 11254932 |
Conditionally active biological proteins |
Hwai Wen Chang, Gerhard Frey |
2022-02-22 |
$1,821,000 |
| 11254742 |
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Hwai Wen Chang, Gerhard Frey |
2022-02-22 |
$1,821,000 |
| 11149088 |
Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereof |
Hwai Wen Chang, Gerhard Frey |
2021-10-19 |
$15,274,000 |
| 11111288 |
Conditionally active chimeric antigen receptors for modified t-cells |
Hwai Wen Chang, Gerhard Frey |
2021-09-07 |
$20,126,000 |
| 10954288 |
Modified antibody regions and uses thereof |
Gerhard Frey, Hwai Wen Chang |
2021-03-23 |
$36,186,000 |